Endocrine Abstracts

Background: There is clear evidence that achieving optimal glycaemic control in type 1diabetes reduces the complications of diabetes. Increased technology use is associated with lower HbA1c. NICE target HbA1c is 48 mmol/mmol.Objective: Are there differences in HbA1c between patients with Type 1 diabetes using continuous glucose monitoring sensor (CGM) or hybrid closed loops in real world setting in paediatric patients at...